Jazz Pharmaceuticals plc — Director's Dealing 2017

Mar 7, 2017

SEC Form 4/A — Form 4/A

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2017-02-27

Reporting Person: Hooper Suzanne Sawochka (EVP & General Counsel)

Holdings (Non-Derivative)

Security	Shares	Ownership
Ordinary Shares	34236	Direct

Footnotes

F1: This Form 4 amends the Form 4 filed on March 1, 2017. Due to a technical error, the amount of securities beneficially owned by the Reporting Person following the Reported Transaction in Table I was overstated by 35,000 shares.